Clinical Trial Update: Pembrolizumab and Induction Chemotherapy in Locally Advanced HNSCC [Phase 2]

View source ↗

Summary

This clinical trial update reports a Phase 2 study evaluating pembrolizumab in combination with induction chemotherapy for locally advanced head and neck squamo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Squamous Cell Carcinoma

Drugs mentioned

• KEYTRUDA (PEMBROLIZUMAB)

Snippet

Sponsor: Guangdong Provincial People's Hospital | Conditions: Head and Neck Squamous Cell Carcinoma | Phase 2 | Status: RECRUITING